Table 3.
Case no. | Sample studied | EMILIN2 18p11.32-31 | DCC 18q21.2 | BCL2 18q21.33 | CDH19 18q22.1 | CDH1 16q22.1 | SDHD 11q.23.1 |
---|---|---|---|---|---|---|---|
20 |
P |
2/2 |
2/2 |
2/2 |
2/2 |
2/2 |
2/2 |
20 |
M (reg) |
-/2 |
-/2 |
-/2 |
-/2 |
-/2 |
-/2 |
21 |
M1 (ova) |
-/1 |
-/1 |
-/1 |
-/1 |
-/1 |
-/1 |
21 |
M2 (ova) |
1/2 |
1/2 |
1/1 |
1/1 |
1/2 |
1/1 |
23 |
P |
-/2 |
-/2 |
-/2 |
-/2 |
-/2 |
-/2 |
23 |
M (reg) |
2/2 |
2/2 |
2/2 |
2/2 |
2/2 |
2/2 |
24 |
M (reg) |
-/1 |
-/1 |
-/1 |
-/1 |
-/2 |
-/2 |
24 |
M (reg) |
1/1 |
1/1 |
1/1 |
1/1 |
2/2 |
2/2 |
26 |
P |
1/1 |
1/2 |
1/2 |
1/2 |
2/2 |
2/2 |
26 |
M (reg) |
-/2 |
-/2 |
-/2 |
-/2 |
-/1 |
-/2 |
27 |
P |
1/2 |
2/2 |
2/2 |
2/2 |
1/2 |
1/2 |
27 |
M (reg) |
2/2 |
2/3 |
2/2 |
2/3 |
2/2 |
2/2 |
28 |
P |
-/1 |
-/1 |
-/1 |
-/1 |
-/2 |
-/2 |
28 |
M (reg) |
1/1 |
1/1 |
1/1 |
1/2 |
2/2 |
2/2 |
29 |
P |
2/2 |
2/3 |
2/2 |
2/3 |
2/2 |
2/2 |
29 |
M (reg) |
-/2 |
-/2 |
-/2 |
-/2 |
-/2 |
-/2 |
30 |
P |
-/1 |
-/2 |
-/1 |
-/1 |
-/2 |
-/2 |
30 |
M (reg) |
1/1 |
1/2 |
1/1 |
1/2 |
2/2 |
2/2 |
31 |
P |
1/1 |
2/2 |
2/2 |
2/2 |
2/1 |
2/1 |
31 |
M (reg) |
-/1 |
-/2 |
-/2 |
-/2 |
-/1 |
-/2 |
32 |
P |
-/1 |
-/1 |
-/1 |
-/1 |
-/2 |
-/2 |
32 | M (reg) | 1/1 | 1/1 | 1/1 | 1/1 | 2/2 | 2/2 |
P = primary; M = metastasis; ova = ovarial; reg = regional 1 = loss; 2 = no abnormality; 3 = gain; - = not analyzed.
Chomosomal locations are according to the ensembl database (http://www.ensembl.org).